IP Library Granted Patent US 9,296,792
Granted Patent B2
US 9,296,792 · App. 13/901,392 · Granted Mar 29, 2016

Ordered flagellin array as an immunostimulant

Inventors: Yuan Lu (Palo Alto, CA); James Robert Swartz (Menlo Park, CA)
Assignee: The Board of Trustees of the Leland Stanford Junior University
C07K14/255A61K39/12A61K39/145A61K39/39A61K2039/5258A61K2039/55516A61K2039/6068C07K2319/00C12N2730/10134
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,296,792
App. No.
13/901,392
Granted
Mar 29, 2016
Kind
B2
Abstract

Bacterial flagellin protein is modified to improve adjuvant activity.

Claims (13)

1. An adjuvant formulation comprising: an ordered array comprising: flagellin protein covalently linked through an unnatural amino acid to a virus-like particle (VLP) wherein the flagellin protein is modified to: (a) comprise the unnatural amino acid at a site corresponding to M1 of SEQ ID NO:1, wherein the unnatural amino acid is selected from homopropargylglycine (HPG), p-acetyl-L-phenylalanine, p-propargyloxyphenylalanine, and p-azido-L-phenylalanine; and (b) methionine residues corresponding to M310 and M466 of SEQ ID NO:1 are substituted with a non-polar amino acid other than methionine; and a pharmaceutically acceptable excipient.

2. The adjuvant formulation of claim 1 , wherein the flagellin protein comprises SEQ ID NO:7.

3. A flagellin protein modified to comprise (a) an unnatural amino acid selected from homopropargylglycine (HPG), p-acetyl-L-phenylalanine, p-propargyloxyphenylalanine, and p-azido-L-phenylalanine at a site corresponding to amino acid residue M1, of SEQ ID NO:1; and (b) methionine residues corresponding to M310 and M466 of SEQ ID NO:1 are substituted with a non-polar amino acid other than methionine.

4. The flagellin protein of claim 3 , wherein the protein comprises a single unnatural amino acid.

5. The flagellin protein of claim 3 , wherein the unnatural amino acid is homopropargylglycine (HPG).

6. A flagellin protein comprising a homopropargylglycine or methionine at the amino acid position corresponding to G239 of SEQ ID NO:1.

7. The flagellin protein of claim 6 , wherein the methionine residues corresponding to M310 and M466 of SEQ ID NO:1 are substituted with a non-polar amino acid other than methionine.

8. The flagellin protein of claim 6 , having the amino acid sequence of SEQ ID NO:3.

9. A flagellin protein modified to comprise

(a) homopropargylglycine (HPG) at the amino acid residue corresponding to M1 of SEQ ID NO:1

(b) an amino acid substitution selected from A2I or A2L; and

(c) methionine residues corresponding to M310 and M466 of SEQ ID NO:1 are substituted with a non-polar amino acid other than methionine.

10. A flagellin protein having the amino acid sequence of SEQ ID NO:7.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2013
From: LU, YUAN; SWARTZ, JAMES ROBERT
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 031002/0234 →
CONFIRMATORY LICENSE Recorded May 31, 2013
From: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 030519/0989 →
Continuity (2)
Provisional Application 61650887 · May 23, 2012
Related Publication 20130323281A1 · Dec 5, 2013